COVID-19

The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India

Sameer Kolhe, President, Maypharm Life Sciences highlights that COVID-19 brings some ‘challenging’ markets within reach for the…

There are several reports about intellectual property rights hindering or potentially hindering timely provisioning of affordable…

Employee safety remains the primary business concern across all geographies, followed by the pandemic’s impact on supply chains

The Indian pharma company has partnered with RDIF to conduct clinical trials Russian COVID-19 vaccine

The agreement will enable 25 per cent of Egypt's population to have access to the Sputnik V vaccine

This viral neutralization efficiency was independently verified by the National Institute for Biological Standards and Control

Teicoplanin is an FDA-approved glycopeptide antibiotic used to treat gram-positive bacterial infections with low toxicity profile…

Fevindo - 400 will be made available at all government approved COVID care centres and selected medical practitioners across the…

PM Modi had assured that India'sproduction and delivery capacity in vaccines will be used to help all humanity in fighting this…